Diversion Control Division, US Department of Justice, Drug Enforcement Administration

RESOURCES > Federal Register Notices > Rules - 1999

Rules - 1999

Drug Scheduling Actions

Placement of Zaleplon into Schedule IV (September 13, 1999)

Rescheduling of the Food and Drug Administration Approved Product Containing Synthetic Dronabinol [(-)-D9-(trans)-Tetrahydrocannabinol] in Sesame Oil and Encapsulated in Soft Gelatin Capsules From Schedule II to Schedule III - Correction  (August 4, 1999)

Placement of Ketamine into Schedule III - Correction (July 22, 1999)

Placement of Ketamine into Schedule III (July 13, 1999)

Rescheduling of the Food and Drug Administration Approved Product Containing Synthetic Dronabinol [(-)-D9-(trans)-Tetrahydrocannabinol] in Sesame Oil and Encapsulated in Soft Gelatin Capsules From Schedule II to Schedule III  (July 2, 1999)

Proposed Placement of Zaleplon into Schedule IV - Correction (May 11, 1999)

Proposed Placement of Zaleplon Into Schedule IV (May 5, 1999)

Proposed Placement of Ketamine Into Schedule III (April 9, 1999)

Proposed Placement of Ketamine Into Schedule III - Withdrawal (April 9, 1999)

Exemption of Chemical Mixtures (February 12, 1999)

Placement of Modafinil Into Schedule IV (January 27, 1999)

Registration / Record Keeping/ Reporting

Chemical Registration and Reregistration Fees - Correction (December 16, 1999)

Chemical Registration and Reregistration Fees (December 1, 1999)

Temporary Exemption From Chemical Registration for Distributors of Pseudoephedrine and Phenylpropanolamine Products (July 27, 1999)

NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Publishing Office (GPO).

Emergency Disaster Relief
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility